Session Z - Paul de Bakker


Paul de Bakker lead a research team studying the genetic basis of complex traits and common diseases. Previously, he has actively contributed to the human HapMap, the design of SNP genotyping arrays and the subsequent discovery of dozens of disease genes through genome-wide association studies (GWAS) in a wide range of immune-related, inflammatory and cardiovascular diseases. Ongoing projects relevant for the BCRM include the Genome of the Netherlands Project to create a national sequencing resource of the Dutch population (funded by BBMRI-NL), a large-scale genome-wide association study of ischemic stroke as part of the international Stroke Genetics Network (SiGN) study (funded by the NIH/NINDS), and whole-genome sequencing of ALS patients (in collaboration with Prof. Leonard van den Berg and Dr. Jan Veldink). Another active interest is the characterization of the major histocompatibility complex (MHC) -- a region on human chromosome 6 with the highest number of validated disease associations identified to date (including schizophrenia). Paul de Bakker is a member of the Scientific Planning Committee of the European Society of Human Genetics (ESHG), Steering Committee member of the Biobanking and Biomolecular Research Infrastructure (BBMRI-NL), and a Scientific Board member of the LifeLines Cohort Study (a prospective population based cohort of >165,000 individuals).

More information

Abstract session Z (keynote lecture on May 21, 16:15 h)

Inherited and de novo variation in human genomes

The abstacts will follow shortly.